STEVEN REICHLING Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEVEN REICHLING.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVEN REICHLING. STEVEN REICHLING is CFO in Accelerate Diagnostics, Inc ($AXK) and CHIEF FINANCIAL OFFICER in Accelerate Diagnostics, Inc ($AXK).
Latest Insider Trading Transactions of STEVEN REICHLING
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 14 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 0.00 | 27,392 | 0 | 0 | |
May 14 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Sell | S | 6.76 | 8,303 | 56,128 | 34,672 | 43 K to 34.7 K (-19.32 %) |
May 14 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 0.00 | 27,392 | 0 | 42,975 | 15.6 K to 43 K (+175.78 %) |
Mar 16 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | A | 0.00 | 113,265 | 0 | 140,657 | |
Mar 16 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | A | 0.00 | 27,392 | 0 | 27,392 | |
Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,142 | 0 | 0 | |
Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Sell | S | 7.37 | 859 | 6,331 | 15,583 | 16.4 K to 15.6 K (-5.22 %) |
Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 0.00 | 3,142 | 0 | 16,442 | 13.3 K to 16.4 K (+23.62 %) |
Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,142 | 0 | 0 | |
Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Sell | S | 7.37 | 859 | 6,331 | 15,583 | 16.4 K to 15.6 K (-5.22 %) |
Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 0.00 | 3,142 | 0 | 16,442 | 13.3 K to 16.4 K (+23.62 %) |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 2.98 | 25,000 | 74,500 | 50,000 | |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 2.98 | 24,910 | 74,232 | 75,000 | |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 2.98 | 20,761 | 61,868 | 99,910 | |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Sell | S | 15.25 | 25,000 | 381,250 | 13,300 | 38.3 K to 13.3 K (-65.27 %) |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 2.98 | 25,000 | 74,500 | 38,300 | 13.3 K to 38.3 K (+187.97 %) |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Sell | S | 12.50 | 24,910 | 311,375 | 13,300 | 38.2 K to 13.3 K (-65.19 %) |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 2.98 | 24,910 | 74,232 | 38,210 | 13.3 K to 38.2 K (+187.29 %) |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Sell | S | 10.55 | 20,761 | 219,029 | 13,300 | 34.1 K to 13.3 K (-60.95 %) |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 2.98 | 20,761 | 61,868 | 34,061 | 13.3 K to 34.1 K (+156.10 %) |
Nov 12 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 2.98 | 39,329 | 117,200 | 120,671 | |
Nov 12 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Sell | S | 9.50 | 39,329 | 373,626 | 13,300 | 52.6 K to 13.3 K (-74.73 %) |
Nov 12 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 2.98 | 39,329 | 117,200 | 52,629 | 13.3 K to 52.6 K (+295.71 %) |
Jul 01 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | A | 0.00 | 3,142 | 0 | 3,142 | |
Mar 27 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | A | 16.90 | 12,634 | 213,515 | 12,634 | |
Mar 26 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | A | 5.93 | 67,061 | 397,672 | 67,061 | |
Mar 26 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | A | 5.93 | 20,118 | 119,300 | 20,118 | |
Mar 02 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 2.98 | 10,000 | 29,800 | 160,000 | |
Mar 02 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 2.98 | 10,000 | 29,800 | 12,300 | 2.3 K to 12.3 K (+434.78 %) |
Jan 03 2019 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 11.50 | 16,604 | 190,946 | 16,604 | |
Jan 03 2019 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 11.50 | 59,830 | 688,045 | 59,830 | |
Nov 28 2018 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | CHIEF FINANCIAL OFF ... | Buy | P | 13.13 | 850 | 11,161 | 2,300 | 1.5 K to 2.3 K (+58.62 %) |
Nov 13 2018 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | CHIEF FINANCIAL OFF ... | Buy | P | 14.72 | 750 | 11,040 | 1,450 | 700 to 1.5 K (+107.14 %) |
Mar 21 2018 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 22.40 | 5,000 | 112,000 | 5,000 | |
Mar 13 2018 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 25.95 | 20,000 | 519,000 | 20,000 | |
Mar 13 2018 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 25.95 | 8,032 | 208,430 | 8,032 | |
Jun 23 2017 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | CHIEF FINANCIAL OFF ... | Option Exercise | M | 2.98 | 30,000 | 89,400 | 170,000 | |
Jun 23 2017 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | CHIEF FINANCIAL OFF ... | Sell | S | 28.90 | 30,000 | 867,000 | 700 | 30.7 K to 700 (-97.72 %) |
Jun 23 2017 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | CHIEF FINANCIAL OFF ... | Buy | M | 2.98 | 30,000 | 89,400 | 30,700 | 700 to 30.7 K (+4,285.71 %) |
Feb 27 2017 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 24.45 | 15,000 | 366,750 | 15,000 | |
Feb 27 2017 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 24.45 | 7,836 | 191,590 | 7,836 | |
Mar 18 2016 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 12.49 | 30,000 | 374,700 | 253,045 | |
Mar 18 2016 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 12.49 | 3,296 | 41,167 | 223,045 | |
Oct 01 2015 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | CFO | Buy | P | 15.23 | 600 | 9,138 | 700 | 100 to 700 (+600.00 %) |
Apr 06 2015 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | CFO | Option Exercise | A | 22.92 | 3,588 | 82,237 | 219,749 |
Page: 1